These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35796499)

  • 1. Soft tissue sarcoma incidences and clinical characteristics are significantly different in France and Taiwan.
    Chen TW; Chiang RC; Le Cesne A; Hsieh YC; Italiano A; Yang YW; Penel N; Lee WC; Bompas E; Valentin T; Anract P; Firmin N; Duffaud F; Cheng AL; Ducimetiere F; Chan KA; Blay JY
    Cancer; 2022 Sep; 128(18):3360-3369. PubMed ID: 35796499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups.
    Gronchi A; Palmerini E; Quagliuolo V; Martin Broto J; Lopez Pousa A; Grignani G; Brunello A; Blay JY; Tendero O; Diaz Beveridge R; Ferraresi V; Lugowska I; Merlo DF; Fontana V; Marchesi E; Braglia L; Donati DM; Palassini E; Bianchi G; Marrari A; Morosi C; Stacchiotti S; Bagué S; Coindre JM; Dei Tos AP; Picci P; Bruzzi P; Casali PG
    J Clin Oncol; 2020 Jul; 38(19):2178-2186. PubMed ID: 32421444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Phase II Trial of Sorafenib and Dacarbazine for Leiomyosarcoma, Synovial Sarcoma, and Malignant Peripheral Nerve Sheath Tumors.
    D'Adamo DR; Dickson MA; Keohan ML; Carvajal RD; Hensley ML; Hirst CM; Ezeoke MO; Ahn L; Qin LX; Antonescu CR; Lefkowitz RA; Maki RG; Schwartz GK; Tap WD
    Oncologist; 2019 Jun; 24(6):857-863. PubMed ID: 30126857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of soft tissue sarcoma in Taiwan: A nationwide population-based study (2007-2013).
    Hung GY; Horng JL; Chen PC; Lin LY; Chen JY; Chuang PH; Chao TC; Yen CC
    Cancer Epidemiol; 2019 Jun; 60():185-192. PubMed ID: 31055220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidences of Primary Soft Tissue Sarcoma Diagnosed on Extremities and Trunk Wall: A Population-Based Study in Taiwan.
    Hung GY; Yen CC; Horng JL; Liu CY; Chen WM; Chen TH; Liu CL
    Medicine (Baltimore); 2015 Oct; 94(41):e1696. PubMed ID: 26469906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of malignant soft-tissue sarcomas of the limbs.
    Renn A; Adejolu M; Messiou C; Bhaludin B; Strauss DC; Thway K; Moskovic E
    Clin Radiol; 2021 Dec; 76(12):940.e1-940.e16. PubMed ID: 34607656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rare primary bone sarcomas: imaging-pathological correlation.
    Berkeley R; Andrei V; Saifuddin A
    Skeletal Radiol; 2021 Aug; 50(8):1491-1511. PubMed ID: 33410967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New benchmarks to design clinical trials with advanced or metastatic liposarcoma or synovial sarcoma patients: An EORTC - Soft Tissue and Bone Sarcoma Group (STBSG) meta-analysis based on a literature review for soft-tissue sarcomas.
    Kantidakis G; Litière S; Neven A; Vinches M; Judson I; Blay JY; Wardelmann E; Stacchiotti S; D'Ambrosio L; Marréaud S; van der Graaf WTA; Kasper B; Fiocco M; Gelderblom H
    Eur J Cancer; 2022 Oct; 174():261-276. PubMed ID: 36116829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histology-Specific Prognostication for Radiation-Associated Soft Tissue Sarcoma.
    Bartlett EK; Sharma A; Seier K; Antonescu CR; Agaram NP; Jadeja B; Rosenbaum E; Chi P; Brennan MF; Qin LX; Alektiar KM; Singer S
    JCO Precis Oncol; 2022 Oct; 6():e2200087. PubMed ID: 36240470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current molecular and therapeutic advances in liposarcoma, rhabdomyosarcoma, leiomyosarcoma, synovial sarcoma, and angiosarcoma.
    Tanriverdi O; Yildiz A
    J Oncol Pharm Pract; 2022 Apr; 28(3):635-645. PubMed ID: 35043739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological characteristics and prognostic factors of T1 (≤5 cm) soft tissue sarcoma -- a comparative study with T2 (>5 cm) soft tissue sarcoma.
    Kang S; Han I; Lee S; Kim W; Kim H
    Eur J Surg Oncol; 2014 Apr; 40(4):406-11. PubMed ID: 24388741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of soft tissue sarcoma and beyond: a population-based prospective study in 3 European regions.
    Mastrangelo G; Coindre JM; Ducimetière F; Dei Tos AP; Fadda E; Blay JY; Buja A; Fedeli U; Cegolon L; Frasson A; Ranchère-Vince D; Montesco C; Ray-Coquard I; Rossi CR
    Cancer; 2012 Nov; 118(21):5339-48. PubMed ID: 22517534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcoma incidence worldwide: regional differences in histology and molecular subtypes.
    Lee MJ; Chen TW
    Curr Opin Oncol; 2024 Jul; 36(4):276-281. PubMed ID: 38726812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence of unplanned excision in patients with soft tissue sarcoma: Reports from the Bone and Soft Tissue Tumor registry in Japan.
    Nakamura T; Kawai A; Sudo A
    J Orthop Sci; 2022 Mar; 27(2):468-472. PubMed ID: 33558102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma.
    De Sanctis R; Marrari A; Marchetti S; Mussi C; Balzarini L; Lutman FR; Daolio P; Bastoni S; Bertuzzi AF; Quagliuolo V; Santoro A
    Drug Des Devel Ther; 2015; 9():5785-91. PubMed ID: 26604682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verticillin A Inhibits Leiomyosarcoma and Malignant Peripheral Nerve Sheath Tumor Growth via Induction of Apoptosis.
    Zewdu A; Lopez G; Braggio D; Kenny C; Constantino D; Bid HK; Batte K; Iwenofu OH; Oberlies NH; Pearce CJ; Strohecker AM; Lev D; Pollock RE
    Clin Exp Pharmacol; 2016 Nov; 6(6):. PubMed ID: 28184331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eribulin in Patients with Liposarcoma and Leiomyosarcoma: A Retrospective Single-Center Experience.
    Steinbrecher O; Brodowicz T; Raderer M; Scharrer A; Fabsits J; Lamm W
    Oncology; 2023; 101(2):89-95. PubMed ID: 36273457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of MLN8237 (Alisertib) in advanced/metastatic sarcoma.
    Dickson MA; Mahoney MR; Tap WD; D'Angelo SP; Keohan ML; Van Tine BA; Agulnik M; Horvath LE; Nair JS; Schwartz GK
    Ann Oncol; 2016 Oct; 27(10):1855-60. PubMed ID: 27502708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.
    Pollack SM; He Q; Yearley JH; Emerson R; Vignali M; Zhang Y; Redman MW; Baker KK; Cooper S; Donahue B; Loggers ET; Cranmer LD; Spraker MB; Seo YD; Pillarisetty VG; Ricciotti RW; Hoch BL; McClanahan TK; Murphy E; Blumenschein WM; Townson SM; Benzeno S; Riddell SR; Jones RL
    Cancer; 2017 Sep; 123(17):3291-3304. PubMed ID: 28463396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of treatment-induced pathologic necrosis in extremity and truncal soft tissue sarcoma after neoadjuvant chemoradiotherapy.
    Mullen JT; Hornicek FJ; Harmon DC; Raskin KA; Chen YL; Szymonifka J; Yeap BY; Choy E; DeLaney TF; Nielsen GP
    Cancer; 2014 Dec; 120(23):3676-82. PubMed ID: 25081640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.